Skip to content

Clinical trials

Phase 3 Hematologic Diseases trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Diseases Phase: Phase 3 Country / region: Belgium Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20121
20131
20144
20151
20171
20191
20201
20214
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting5
Terminated4
Enrolling by invitation1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Loxo Oncology, Inc.4
Novartis Pharmaceuticals3
Ariad Pharmaceuticals2
CTI BioPharma2
Pfizer2
BioMarin Pharmaceutical1
Sierra Oncology LLC - a GSK company1
Sunesis Pharmaceuticals1
Vertex Pharmaceuticals Incorporated1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Diseases17
Bone Marrow Diseases7
Myeloproliferative Disorders7
Leukemia4
Lymphoma, B-Cell4
Lymphoma, Non-Hodgkin4
Polycythemia Vera4
Anemia3
Leukemia, Lymphocytic, Chronic, B-Cell3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive3

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.